Article info
PDFInterstitial lung disease
Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention
- Correspondence to Oliver Eickelberg, Comprehensive Pneumology Center, University Hospital of the Ludwig Maximilians University Munich and Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764 Neuherberg/München, Germany; oliver.eickelberg{at}helmholtz-muenchen.de
Citation
Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention
Publication history
- Received December 30, 2009
- Accepted May 4, 2010
- First published July 29, 2010.
Online issue publication
September 01, 2022
Article Versions
- Previous version (29 April 2016).
- You are viewing the most recent version of this article.
Web Only Data THORAX.2010.134353
Files in this Data Supplement:
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.